- Home
- TR vs CNTA Comparison
TR vs CNTA Comparison
Compare TR & CNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TR
- CNTA
- Stock Information
- Founded
- TR 1896
- CNTA 2020
- Country
- TR United States
- CNTA United Kingdom
- Employees
- TR N/A
- CNTA N/A
- Industry
- TR Specialty Foods
- CNTA Biotechnology: Pharmaceutical Preparations
- Sector
- TR Consumer Staples
- CNTA Health Care
- Exchange
- TR Nasdaq
- CNTA Nasdaq
- Market Cap
- TR 2.9B
- CNTA 2.3B
- IPO Year
- TR N/A
- CNTA 2021
- Fundamental
- Price
- TR $42.87
- CNTA $22.52
- Analyst Decision
- TR
- CNTA Strong Buy
- Analyst Count
- TR 0
- CNTA 8
- Target Price
- TR N/A
- CNTA $31.29
- AVG Volume (30 Days)
- TR 212.9K
- CNTA 1.0M
- Earning Date
- TR 10-27-2025
- CNTA 11-11-2025
- Dividend Yield
- TR 0.85%
- CNTA N/A
- EPS Growth
- TR N/A
- CNTA N/A
- EPS
- TR 1.24
- CNTA N/A
- Revenue
- TR $722,849,000.00
- CNTA $15,000,000.00
- Revenue This Year
- TR N/A
- CNTA N/A
- Revenue Next Year
- TR N/A
- CNTA N/A
- P/E Ratio
- TR $33.68
- CNTA N/A
- Revenue Growth
- TR N/A
- CNTA 118.88
- 52 Week Low
- TR $28.32
- CNTA $9.60
- 52 Week High
- TR $43.97
- CNTA $24.57
- Technical
- Relative Strength Index (RSI)
- TR 61.26
- CNTA 54.48
- Support Level
- TR $41.55
- CNTA $21.78
- Resistance Level
- TR $43.68
- CNTA $23.08
- Average True Range (ATR)
- TR 0.98
- CNTA 0.96
- MACD
- TR -0.08
- CNTA -0.32
- Stochastic Oscillator
- TR 68.79
- CNTA 26.34
About TR Tootsie Roll Industries Inc.
Tootsie Roll Industries Inc manufactures and sells confectionery products. Notable varieties include Tootsie Roll and Tootsie Pops, Charms, Blow-Pops, Dots, Junior Mints, Sugar Daddy and Sugar Babies, Andes, Dubble Bubble, Razzles among others. The company sells its products to wholesale distributors and directly to retail stores. Geographically, it generates a majority of its revenue from the United States and rest from Canada, Mexico and other regions.
About CNTA Centessa Pharmaceuticals plc
Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include: SerpinPC for Hemophilia A, B; LB101 for Solid Tumors; ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders; MGX292 Pulmonary Arterial Hypertension (PAH); and Undisclosed for Solid Tumors.